Resolution of inflammation: from basic concepts to clinical application
Open Access
- 27 November 2019
- journal article
- editorial
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 41 (6) , 627-631
Abstract
No abstract availableThis publication has 86 references indexed in Scilit:
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2013
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative ColitisNew England Journal of Medicine, 2012
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque PsoriasisNew England Journal of Medicine, 2012
- Ulcerative ColitisNew England Journal of Medicine, 2011
- Inflammation and Colon CancerGastroenterology, 2010
- Predicting the response to infliximab from trough serum levelsGut, 2009
- IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cellsNature Immunology, 2008
- TREM-1–expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseasesJournal of Clinical Investigation, 2007
- Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM TrialGastroenterology, 2007
- Transforming growth factor induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitisGut, 2006